Konferenzschrift | Kongress
Viral safety and evaluation of viral clearance from biopharmaceutical products : proceedings of a symposium, Natcher Conference Center, Bethesda, Maryland, USA, June 14 - 16, 1995 ; 73 tables
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783805563918
3805563914
- Dimensions
-
24 cm
- Extent
-
X, 342 S.
- Language
-
Deutsch
- Notes
-
Ill., graph. Darst.
Literaturangaben
- Bibliographic citation
-
Developments in biological standardization ; Vol. 88
- Keyword
-
Pharmazeutische Technologie
Gentechnologie
Mikrobielle Kontamination
Arzneimittelsicherheit
- Event
-
Veröffentlichung
- (where)
-
Basel, Freiburg [Breisgau], Paris, London, New York, New Delhi, Bangkok, Singapore, Tokyo, Sydney
- (who)
-
Karger
- (when)
-
1996
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
2025-06-11T13:59:24+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Konferenzschrift
- Kongress
Associated
Time of origin
- 1996
Other Objects (12)
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
Variability and viral safety of cell culture media to ensure process performance in the biopharmaceutical industry
Viral infections
Viral hepatitis
Viral Glomerulopathy
Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice
Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance
A viral disturbance
Plant viral vectors
Marketing goes viral
Viral heart disease
Viral expression vectors
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
Variability and viral safety of cell culture media to ensure process performance in the biopharmaceutical industry
Viral infections
Viral hepatitis
Viral Glomerulopathy
Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice
Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance
A viral disturbance
Plant viral vectors
Marketing goes viral
Viral heart disease
Viral expression vectors
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
Variability and viral safety of cell culture media to ensure process performance in the biopharmaceutical industry
Viral infections
Viral hepatitis
Viral Glomerulopathy
Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice
Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance
A viral disturbance
Plant viral vectors
Marketing goes viral
Viral heart disease